APA (7th ed.) Citation

Eratne, D., Li, Q. X., Lewis, C., Dang, C., Kang, M. J., Grewal, J., . . . Lund University, F. o. M. (2025). Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort. Journal of Neurology, 272(1), . https://doi.org/10.1007/s00415-024-12732-3

Chicago Style (17th ed.) Citation

Eratne, Dhamidhu, et al. "Strong Diagnostic Performance of Plasma Ptau217 for CSF Biomarker-defined Young-onset Alzheimer Disease in a Diagnostically Heterogeneous Clinical Cohort." Journal of Neurology 272, no. 1 (2025). https://doi.org/10.1007/s00415-024-12732-3.

MLA (9th ed.) Citation

Eratne, Dhamidhu, et al. "Strong Diagnostic Performance of Plasma Ptau217 for CSF Biomarker-defined Young-onset Alzheimer Disease in a Diagnostically Heterogeneous Clinical Cohort." Journal of Neurology, vol. 272, no. 1, 2025, https://doi.org/10.1007/s00415-024-12732-3.